Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 30, 2017
Biotech innovation hub LabCentral has signed Science Exchange as a sponsor to support its life science and biotech resident startups.
read more
Monday, November 20, 2017
Science Exchange announced a strategic partnership with Alector, a biotech company.
read more
Science Exchange announces a collaboration with AUM BioTech, a Philadelphia-based startup, to advance genetic research and significantly cut short drug discovery and development time.
read more
Monday, December 11, 2017
Science 37 and Otsuka announced a strategic collaboration to support efforts to further digitize Otsuka’s mobile clinical study protocols with a focus on psychiatry and behavioral health.
read more
Wednesday, November 27, 2019
Science 37 has announced David Coman has joined the company as its chief executive officer.
read more
Science 37 Holdings, Inc. announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation. The nearly two-week review included, but was not limited to, the Science 37 Metasite™ model and internal processes,...
read more
In response to the U.S. National Alzheimer's Project Act and the recent NIH mandate for single IRB review in multisite clinical trials, the NBREC and Schulman IRB have developed an alliance to improve the quality and efficiency of Alzheimer's disease...
read more
Schulman IRB announced its commercial institutional biosafety committee service is now open.
read more
Wednesday, December 19, 2018
Schrödinger and TB Alliance announced a three-year research collaboration to speed the development of next-generation tuberculosis treatments.
read more
Monday, December 03, 2018
Scientist.com and Allele have partnered to develop nanoantibodies for therapeutic applications.
read more
Tuesday, January 28, 2025
Sapio Sciences announced that Schrödinge has adopted the Sapio Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules.
read more
Schrödinger announced receipt of a preclinical milestone payment from Sanofi in a drug discovery program advancing as part of a multi-year, multi-target collaboration
read more
Wednesday, January 23, 2019
Schrödinger announced the appointment of Rosana Kapeller, M.D., Ph.D., to its board of directors.
read more
Schrödinger has entered into a three-year agreement with Google Cloud to increase the speed and capacity of its physics-based computational platform for drug discovery.
read more
Wednesday, October 11, 2017
Schreiner MediPharm recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG.
read more